Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Advisor Biotechnology Fund

+ Add to Watchlist

FBTAX:US

27.47 USD 0.33 1.19%

As of 09:29:30 ET on 02/27/2015.

Snapshot for Fidelity Advisor Biotechnology Fund (FBTAX)

Year To Date: +12.60% 3-Month: +14.80% 3-Year: +43.07% 52-Week Range: 17.27 - 27.80
1-Month: +3.96% 1-Year: +22.58% 5-Year: +33.82% Beta vs MXWO: 1.03

Mutual Fund Chart for FBTAX

No chart data available.
  • FBTAX:US 27.47
  • 1M
  • 1Y
Interactive FBTAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBTAX

Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-27-2000 Telephone: 1-877-208-0098
Managers: RAJIV KAUL
Web Site: advisor.fidelity.com

Fundamentals for FBTAX

NAV (on 2015-02-27) 27.47
Assets (M) (on 2015-01-30) 2,547.32
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBTAX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-12) 0.42
Dividend Yield (ttm) 2.20

Fees & Expenses for FBTAX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.25
Expense Ratio 1.08

Top Fund Holdings for FBTAX

Filing Date: 12/31/2014
Name Position Value % of Total
Gilead Sciences Inc 1,891,207 178,265,172 8.001%
Celgene Corp 1,540,677 172,340,129 7.736%
Biogen Idec Inc 453,075 153,796,309 6.903%
Alexion Pharmaceuticals Inc 639,024 118,238,611 5.307%
Vertex Pharmaceuticals Inc 916,326 108,859,529 4.886%
Regeneron Pharmaceuticals Inc 248,461 101,931,125 4.575%
Amgen Inc 387,830 61,777,441 2.773%
BioMarin Pharmaceutical Inc 611,761 55,303,194 2.482%
Receptos Inc 450,142 55,146,896 2.475%
Medivation Inc 431,077 42,939,580 1.927%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil